share_log

D. Boral Capital Maintains Buy on Hoth Therapeutics, Maintains $5 Price Target

Benzinga ·  Jan 7 11:18

D. Boral Capital analyst Jason Kolbert maintains Hoth Therapeutics (NASDAQ:HOTH) with a Buy and maintains $5 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment